{
  "pmcid": "7371073",
  "sha256": "3e6d7f2a99ac4936a14a0fdbaec0cb3a036879ae5b7dab95a163dc9b61ecfa26",
  "timestamp_utc": "2025-11-10T00:05:48.636955+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.101931104356641,
    "reading_ease": 44.15700000000001,
    "word_count": 282
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of PRP and Autologous Blood Injections for Lateral Epicondylitis"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "parallel-group, participant- and assessor-blinded trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "adults with clinically diagnosed lateral epicondylitis unresponsive to nonoperative treatment. Exclusion criteria included other upper-limb symptoms and prior elbow surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "to receive PRP, autologous blood, or saline injections"
      },
      "Objective": {
        "score": 1,
        "evidence": "assessed the effectiveness of platelet-rich plasma (PRP) and autologous blood injections versus saline in treating lateral epicondylitis"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pain improvement on the VAS scale at 52 weeks."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Participants were randomised (1:1:1) using computer-generated sequences, concealed from investigators"
      },
      "Blinding": {
        "score": 2,
        "evidence": "participant- and assessor-blinded trial"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 119 participants were randomised: 40 to PRP, 40 to autologous blood, and 39 to saline."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "At 52 weeks, 31 PRP, 38 autologous blood, and 32 saline participants were analysed."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The mean VAS pain difference was -0.2 (95% CI -1.5 to 1.1; p = 0.75) for PRP vs. saline and 0.5 (95% CI -0.7 to 1.7; p = 0.40) for autologous blood vs. saline."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ClinicalTrials.gov."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funded by the local hospital district."
      }
    },
    "total_score": 24,
    "max_score": 25
  }
}